|
MTR expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.84530000000494E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.099840E-03 |
| Normal-vs-Stage2 |
1.096450E-02 |
| Normal-vs-Stage3 |
1.68599999994523E-06 |
| Normal-vs-Stage4 |
2.92890000030965E-08 |
| Stage1-vs-Stage2 |
8.331000E-01 |
| Stage1-vs-Stage3 |
3.604300E-02 |
| Stage1-vs-Stage4 |
1.096000E-03 |
| Stage2-vs-Stage3 |
2.228000E-01 |
| Stage2-vs-Stage4 |
3.476000E-02 |
| Stage3-vs-Stage4 |
1.981820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.003010E-04 |
| Normal-vs-AfricanAmerican |
2.58949999998315E-06 |
| Normal-vs-Asian |
8.082800E-01 |
| Caucasian-vs-AfricanAmerican |
1.019370E-01 |
| Caucasian-vs-Asian |
2.492600E-01 |
| AfricanAmerican-vs-Asian |
5.748500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.10199999999272E-05 |
| Normal-vs-Female |
1.78430999999701E-05 |
| Male-vs-Female |
9.303600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.564320E-04 |
| Normal-vs-Age(41-60Yrs) |
9.5095000000045E-05 |
| Normal-vs-Age(61-80Yrs) |
4.27870000000441E-05 |
| Normal-vs-Age(81-100Yrs) |
8.298500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.547390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.686780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.315400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.408000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.090800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.500200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.067400E-01 |
| Normal-vs-Grade 2 |
3.383400E-03 |
| Normal-vs-Grade 3 |
4.8728000000553E-06 |
| Normal-vs-Grade 4 |
1.25400023698319E-10 |
| Grade 1-vs-Grade 2 |
7.790000E-02 |
| Grade 1-vs-Grade 3 |
2.213900E-02 |
| Grade 1-vs-Grade 4 |
1.99292999999434E-05 |
| Grade 2-vs-Grade 3 |
5.378500E-02 |
| Grade 2-vs-Grade 4 |
2.25720000002205E-06 |
| Grade 3-vs-Grade 4 |
6.620200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.596300E-02 |
| Normal-vs-ccB subtype |
3.75310000000351E-05 |
| ccA subtype-vs-ccB subtype |
2.421700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.64900000000556E-05 |
| Normal-vs-N1 |
8.028200E-04 |
| N0-vs-N1 |
2.596600E-01 |
|
|
